"For pregnant women there are two major causes of death: massive hemorrhage and PPCM, and it is a very sad situation because a time of great happiness turns to great sorrow and the new baby and the father are left alone," said study co-author Professor Alexandre Mebazaa, from the Hopital Lariboisiere, Paris. "Here we have found a way to detect rather quickly whether the woman has PPCM and to treat it quickly and efficiently."
"There's an urgent need for biomarkers of PPCM since the condition can be hard to differentiate from the normal symptoms of pregnancy that include dyspnoea, oedema and palpitations," said Professor Karen Sliwa, a co-author from the University of Cape Town, South Africa.
“The next step will be to confirm our findings in a larger cohort and if they hold we could go on to develop a bed side test similar to NT-pro BNP in HF,” said Professor Sliwa.
About the European Society of CardiologyThe European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.About the Heart Failure Association (HFA)The Heart Failure Association (HFA) is a registered branch of the ESC. Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.For practical information about heart failure aimed at patients, families and caregivers, visit the HFA’s Heart Failure Matters website. Did you want to tweet about our congress? - if you do, please use the official #heartfailure2014 hashtag! Thank youInformation for journalists attending Heart Failure 2014
ESC Press OfficeJacqueline Partarrieupress@escardio.orgTel: +33 6 22 83 45 76 (off site support number)
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved